← Back
Data updated: Mar 29, 2026
CHEPLAPHARM
OncologyMetabolicRespiratory
Specialty
CHEPLAPHARM is a specialty pharmaceutical company focused on Oncology, Metabolic, Respiratory.
1975
Since
13
Drugs
-
Trials
12
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 25%
1 drugs
Metabolic 25%
1 drugs
Respiratory 25%
1 drugs
Immunology 25%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Sanofi big-pharma
Metabolic, Oncology, Immunology, Respiratory
AstraZeneca big-pharma
Oncology, Respiratory, Metabolic, Immunology
Novartis big-pharma
Oncology, Immunology, Respiratory
Boehringer Ingelheim big-pharma
Metabolic, Oncology, Respiratory, Immunology
Merck big-pharma
Oncology, Immunology, Metabolic
Active (9)
Company Info
- First Approval
- 1975-06-04
- Latest
- 2026-01-30
- Applications
- 15